Prestige Consumer Healthcare Inc. Common Stock (PBH)
48.00
-0.23 (-0.48%)
NYSE· Last Trade: May 22nd, 5:20 PM EDT
Detailed Quote
Previous Close
48.23
Open
48.19
Bid
43.29
Ask
55.00
Day's Range
47.18 - 48.42
52 Week Range
42.62 - 87.12
Volume
947,407
Market Cap
2.40B
PE Ratio (TTM)
12.66
EPS (TTM)
3.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
756,092
Chart
About Prestige Consumer Healthcare Inc. Common Stock (PBH)
Prestige Brand Holdings is a consumer goods company that specializes in marketing and distributing a diverse portfolio of over-the-counter healthcare and personal care products. The company focuses on providing solutions in various categories, including feminine hygiene, oral care, and vitamins, with a strong emphasis on brand development and consumer engagement. By utilizing a combination of established and emerging brands, Prestige Brand Holdings aims to meet the evolving needs of consumers while driving growth and profitability within the competitive health and wellness market. Read More
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz continues its investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Shareholders who lost money on Prestige Consumer Healthcare (NYSE: PBH) stock following the Company's Q4 FY 2026 earnings miss are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Prestige Consumer Healthcare (NYSE:PBH) reported a weaker-than-expected fourth quarter as supply constraints in eye care and shipping disruptions tied to conflict in the Middle East weighed on sales, but management said it expects a return to organic growth in fiscal 2027 and outlined a multiyear ou
TARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2026.
TARRYTOWN, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 fourth quarter and year-end earnings release on Wednesday, May 13, 2026 after the market close. The following morning, May 14, at 8:30 a.m. ET, the Company will host a conference call to discuss the results.
In a move that signals a bold return to aggressive brand acquisition, Prestige Consumer Healthcare Inc. (NYSE: PBH) announced on March 20, 2026, that it has entered into a definitive agreement to acquire the iconic Breathe Right nasal strip brand. The $1.045 billion cash transaction with Foundation Consumer Healthcare
TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million.
TARRYTOWN, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and nine months ended December 31, 2025.
TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025.
TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
